Biofeedback for Second Stage of Labor

Sponsor
Assuta Ashdod Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04210908
Collaborator
(none)
100
1
2
32
3.1

Study Details

Study Description

Brief Summary

The purpose of this study is to examine whether transperineal ultrasound as visual biofeedback can be used during labor as an effective tool for shortening the second stage of labor and reducing the need for instrumental delivery, in a prospective randomized design.

Condition or Disease Intervention/Treatment Phase
  • Other: Visual biofeedback
N/A

Detailed Description

Biofeedback provides patients with better control of their body and their physiological reactions respective of the examined process, such as stress/anxiety, sports activity, labor, etc.

Women under epidural anesthesia, may frequently feel lack of control over the birthing process and difficulty in bearing down effectively, which is a very significant part of the second stage of labor.

Transperineal ultrasound during labor is a standard procedure in many medical centers in the world, mainly used to assist obstetricians in evaluating the progress of labor, fetal head position and assessing the chances of successful operative delivery. One of the most common tools used in transperineal ultrasound in measurement of the angle of progression, which has been suggested as a subjective method for assessing fetal station and for predicting successful vaginal delivery. A preliminary non-randomized study raised the possibility that the use of transperineal ultrasound during labor as a biofeedback tool may shorten the second stage of labor.

The purpose of this study is to examine whether this tool can be used during labor as an effective tool for shortening the second stage of labor and reducing the need for instrumental delivery, in a prospective randomized design.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Open label randomized control trialOpen label randomized control trial
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Ultrasound Imaging Biofeedback for Shortening the Second Stage of Labor: a Randomized Prospective Study
Actual Study Start Date :
Apr 30, 2020
Anticipated Primary Completion Date :
Dec 31, 2021
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Biofeedback

The patient will be instructed to bear down during 4 consecutive contractions while monitoring head descent using transperineal ultrasound. In the study group, patients will observe the descent of the head during contraction on the ultrasound display screen.

Other: Visual biofeedback
Patient will observe the descent of the fetal head as they push during contractions

No Intervention: Control

The patient will be instructed to bear down during 4 consecutive contractions while monitoring head descent using transperineal ultrasound. In the control group, patients will not observe the ultrasound display screen.

Outcome Measures

Primary Outcome Measures

  1. Duration of the second stage of labor [Up to 6 hours]

    Minutes from first documentation of full dilatation to delivery.

Secondary Outcome Measures

  1. Mode of delivery [Up to 6 hours]

    Mode of delivery (categorical): spontaneous vaginal, operative vaginal or cesarean

  2. Neonatal 1 minute Apgar score [Up to 6 hours]

    Apgar score at 1 minute after delivery (scale of 0-10)

  3. Neonatal 5 minute Apgar score [Up to 6 hours]

    Apgar score at 5 minute after delivery (scale of 0-10)

  4. Cord pH [Up to 6 hours]

    Umbilical cord blood pH

  5. Postpartum hemorrhage [Up to 24 hours]

    Rate of early postpartum hemorrhage (during first 24 hours)

  6. Maternal perineal tears [Up to 6 hours]

    Maternal perineal tear grade (categorical): None and grades 1-4

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. First labor

  2. Full dilation

  3. Head position between SP-1 and SP+2.

  4. Epidural anesthesia

  5. No contraindication for vaginal delivery

  6. Parturient informed consent

Exclusion Criteria:
  1. Participation in parallel studies.

  2. Category III fetal monitoring requiring immediate delivery.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Assuta Ashdod Hospital Ashdod Israel

Sponsors and Collaborators

  • Assuta Ashdod Hospital

Investigators

  • Principal Investigator: Eran Barzilay, MD PhD, Samson Assuta Ashdod University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Eran Brazilay, MD PhD, Head of the Obstetric and Gynecologic Ultrasound unit, Assuta Ashdod Hospital
ClinicalTrials.gov Identifier:
NCT04210908
Other Study ID Numbers:
  • 0064-19-AAA
First Posted:
Dec 26, 2019
Last Update Posted:
Jul 27, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Eran Brazilay, MD PhD, Head of the Obstetric and Gynecologic Ultrasound unit, Assuta Ashdod Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 27, 2021